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Figure 1. Stress strain diagram of Fibrin gel (left) and the injectable plaster
(right). The ﬁbrin gel does not show any up build of forces and is poorly
adhering to the defect surface. This in contrast to the injectable plaster.
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cartilage-to-cartilage repair models to Sprifermin improves integration
strength and matrix deposition at the interface (as evidenced by con-
trast-enhanced mCT showing a more uniform attenuation by increase in
GAG-containing proteoglycans). In this study, one 24 hour admin-
istrationweekly for 4 weeks leads to an overall better outcome than one
24 hour treatment over one month. This study represents for the ﬁrst
time a biologic (and in particular an FGF) has improved the integration
of cartilage surfaces in a clinically relevant repair model. The ﬁndings
implicates Sprifermin potential usefulness in surgical procedures such
as OATS and in tissue engineering approaches where cartilage like
biomaterials will be required to successfully integrate with native car-
tilage in order to achieve clinical success.
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CHONDROGENESIS FROM HUMAN INDUCED PLURIPOTENT STEM
CELLS: EPIGENETIC CAUSES OF LOW HYPERTROPHY INDUCTION
S. Park, J.-Y. Ko, G.-I. Im. Dongguk Univ. Ilsan Hosp., Goyang, REPUBLIC OF
KOREA
Purpose: The purpose of this studywas to test the in vitro chondrogenic
potential and in vivo capacity for cartilage regeneration of human iPS
(hiPS) cells.
Methods: Cell culture and differentiation of EB We used the hiPSC line
(SBI, cat# SC802A-1) generated by direct delivery of four proteins fused
to a cell penetrating peptide. hiPSCs were passaged to Matrigel-coated
polystyrene plates and cultured in the deﬁned mTeSR1 medium. To
inducemesenchymal differentiation, embryoid bodies were formed and
cultured in suspension for 11 days with hESC growth medium in low-
attachment culture dishes.
Chondrogenic differentiation: Chondrocytic differentiation was
induced by trypsinizing EB to a single cell suspension, diluting cells to a
ﬁnal concentration of 5x105 cells/ml and forming micromass pellets by
centrifugation. Micromass pellets were cultured in 15-ml conical tubes
for 21 days using DMEM/F12 medium,of supplemented with 1% ITS
(insulin-transferrin-selenium), 10-7 M dexamethasone, 50 mM ascor-
bate-2-phosphate, 50 mM L-proline, 1 mM sodium pyruvate and 10ng/
ml TGF-b3.
Analysis for chondrogenic differentiation: After 21 days of in vitro
culture, pellets were analyzed for DNA contents, GAG amount, the
expression of chondrogenic markers, and the methylation status.
Transplantation:The hiPS-pellets or alginate-hiPSCs constructs were
implanted in the osteochondral defect model rat. The rats received daily
injections of cyclosporin A to suppress immune responses in rats. After
6 weeks, the rats were sacriﬁced.
Results: Mesodermal markers increased in EB while undifferentiated ES
markersdisappeared.After 21days of chondrogenic culture inmicromass
pellets, GAG analysis showed that proteoglycan production was sig-
niﬁcantly greater in chondrogenic pellets than in undifferentiated hiPSCs
and EBs. Safranin-O staining demonstrated that the cells in chondrogenic
pellets took on the appearance of immature chondrocytes and secreted
extracellular matrix. The chondrogenic marker gene and protein
expression increased after 21days of pellet culture. The chondrogenic
pellets derived from hiPSCs have very low expression of hypertrophic or
osteogenicmarkers. Also,methylationwas increased in hiPSCs compared
to hBMSCs in the COL10A1promoter. This result suggested the epigenetic
disparity is the cause of the difference in hypertrophy.
When hiPSCs in either pellet state or in alginate hydrogel were
implanted in the osteochondral defects created on the patellar groove of
immunosuppressed rats, the defects implanted with chondro-induced
hiPSCs showed a signiﬁcantly better quality of cartilage repair than the
control defects.
Conclusions: In conclusion, this study provides a proof-of-principle
strategy for using hiPSCs as a cell source for cartilage tissue engineering.
While successful in vitro induction of chondrogenesis with improved
biochemical characteristics were obtained from hiPS cells, the working
mechanisms in the implantation of hiPS cells and strategies for further
improvement of in vivo cartilage repair with hiPS cells should be
investigated in future studies.
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INJECTABLE HYDROGELS FOR CARTILAGE REPAIR
S. Both, R. Wang, P. Dijkstra, M. Karperien. Univ. of Twente, Enschede,
NetherlandsPurpose: To create an injectable hydrogel that can be used to
plaster eroded cartilage surfaces and / or to ﬁll up focal cartilage
defects in a minimally invasive arthroscopic procedure. The plaster
should protect the damaged cartilage surface against further car-
tilage erosion and possess an optimized environment for cartilage
regeneration.
Methods: Over the last years we have develop an injectable plaster by
introducing hydroxyphenyl groups in the backbone of naturally
occurring polymers such as dextran, hyaluronic acid and heparin
which resemble or normally reside in the extracellular cartilage
matrix. This renders an injectable hydrogel which gelates in an
enzymatic peroxidase mediated reaction initiated by non-toxic con-
centrations of H2O2.
From in vitro testing we know that our plaster is biocompatible and that
it supports cartilage formation of incorporated primary chondrocytes,
mesenchymal stromal cells or combinations of both. To further improve
our injectable plaster we have introduced several cell attracting, carti-
lage-mimicking and/or chondrogenesis stimulating elements and
studied cartilage formation. The adhesive properties of the injectable
plaster was compared to clinically used ﬁbrin glue in a customized set
up. Finally pilot studies were performed in fresh horse cadavers to test
whether the plaster could be applied in focal cartilage defects in an
arthroscopic procedure. The repaired joint wasmanually ﬂexed to study
the plaster’s resistance to force.
Results: The incorporation of heparin, hyaluronic acid and chon-
droitin sulphate in a dextran based hydrogel resulted in a che-
moattractant plaster facilitating ingrowth of chondrocytes and
mesenchymal stromal cells. When chondrocytes were incorporated
the addition of these elements potently stimulated neocartilage
formation by encapsulated chondrocytes based on histological
analysis and gene expression of typical cartilage markers like
COL2A, SOX9 and AGC. The binding of the hydrogel to surface of
the defect is important for future clinical applications. Therefore
we compared our hydrogel to clinically used ﬁbrin gel and found
that gel ﬁxation of the injectable plaster is at least 1 order of
magnitude stronger than the gluing properties of ﬁbrin gel (Fig-
ure 1). In addition, rheology showed that the injectable plaster has
improved mechanical properties compared to ﬁbrin gel. Next we
tested our injectable plaster in a minimally invasive surgical pro-
cedure. Thus the gel was injected via arthroscopic procedure in a
full thickness defect in the joint of a horse. Subsequent the knee of
the horse was ﬂexed manually to test the injectable plaster which
remained in its place (Figure 2). Since this was a success we are
currently planning our next in vivo study in which the horses will
be followed in time to see how the plaster reacts in a full load
bearing joint.
Conclusions: We have developed an injectable hydrogel that gelates in
situ using a biocompatible enzymatic cross linking reaction and we
have shown that this hydrogel is chemoattractant for chondrocyte
progenitors and mesenchymal stem cells. We found that gel ﬁxation of
the injectable plaster is stronger than the gluing properties of clinically
used ﬁbrin gel. Next we demonstrated that this hydrogel can be applied
in a minimally invasive arthroscopic procedure in a horse knee and
strongly binds to cartilage and subchondral bone by covalent bonding of
the hydrogel to the native tissue.
We are nowperforming experiments in live animals to test the potential
of these injectable plasters to facilitate regeneration of damaged carti-
lage surfaces.
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S152Figure 2. Applying the injectable plasters in a full thickness chondral
defect during an arthroscopic procedure. Before (A) and after (B) the
injection of the plaster. The initial ﬂuidity ensures complete ﬁlling of the
defect. The plaster remained ﬁxed at the defect site after manual ﬂexion of
the joint.
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USE OF HYALURONAN SCAFFOLD IN COMBINATION WITH FRESH
BONE MARROW TRANSPLANTATION OR WITH MICROFRACTURES
IN TREATMENT OF CARTILAGE DEFECTS OF THE KNEE JOINT
K. Slynarski y, J.M. Deszczynski, Jr. z,y, R. Jopowicz z,y, A. Krzesniak y.
y Lekmed Med. Ctr., Warsaw, Poland; zWarsaw Med. Univ., Warsaw,
Poland
Purpose: Microfracture is a well-established procedure in cartilage
knee surgery. Currently there are many different techniques utilizing
biological implants to support the chondrogenesis. The purpose of
this study is to evaluate the medium-term results of the hyaluronic
scaffold in combination with fresh bone marrow transplantation or
with microfractures in treatment of cartilage defects of the knee
joint.
Methods: A new type of hyaluronic acid membrane Hyalofast (Anika
Therapeutics, Inc. MA, USA) was used as a CHONDROINDUCTIVE
SCAFFOLD that allows attachment and stimulation of mesenchymal
stem cells of bone marrow. In study group we used hyaluronan scaffold
with fresh bone marrow transplantation and in control group the
scaffold was combined with microfractures. Patients were followed
using a Socrates Orthopeadic Outcome Software (Ortholink Pty Ltd,
Australia) database tool to track changes in function and symptoms by
the Lysholm, Tegner and VAS scores along with MRI imaging.
Results: 40 Patients met the inclusion criteria for this study. Both
groups consisted of 20 patients. All defects was grade IIIA (n ¼ 10) and
IIIB (n¼ 20) according to the ICRS classiﬁcation. The mean defect size of
the chondral lesions was 2.7 cm (2) (range 1,4–3,1). Defects were
localized at the medial (n ¼ 12) and lateral (n ¼ 8) condyle, at the
trochlea (n ¼ 12) and at the patella ¼ (8). Based on the imaging eval-
uation a satisfactory outcome was observed in all cases at estimated
intervals. Signiﬁcant improvement (P ¼ 0,002, wilcoxon rank-sum test)
was observed in Lysholm (preop ¼ 61,2 ; 1 year postop ¼ 82,3; 2 year
postop ¼ 85,3) Tegner improvement (2,7) and VAS scores. All patients
returned to sport activities which they performed before the surgery.
No adverse effects related to the implant were observed during the
duration of the study. There was no statisctical difference (p ¼ 0,08) in
the results between both groups.
Conclusions: The use of hyaluronic acid membrane is considered to be
safe and effective procedure for treatment of symptomatic chondral
defects of the knee. The data shows that there is no difference between
two techniques of utilizing mircofractues or bone marrow trans-
plantation at the defect site. However, further studies with long-term
follow-up are needed to determine if the grafted area will maintain
structural and functional integrity over time.
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OSTEOARTHRITIS GRADE AND DECISION MAKING IN CARTILAGE
REPAIR
M. Hurtig. Univ. of Guelph, Guelph, ON, Canada
Objective: A recent survey of surgeons that perform microfracture
demonstrated that there is a wide variation in technique(1). We alsoobserved that experienced surgeons performing microfracture in
cadaveric knees improvised or modiﬁed the technique to accommodate
sclerotic or osteopenic bone as well as curved surfaces. One concernwas
that the obtuse approach angle used to approach a surface curving away
from the surgeon created a furrow-like elongated hole along the joint
surface_ we called this, plowing“. The objective of this expeirment was
to determine if plowing affected the integrity of the subchondral bone
plate.
Methods: Forty-two 10 x 10 x 15 mm cubes were cut from the lateral
femoral condyles of human cadaveric knees. MicroCT (45 micron
resolution) was used to characterize the trabecular bone and sub-
chondral bone plate before and after microfracture. Cubes were potted
and underwent non-destructive testing (a 0.25% pre-strain at a strain
rate of 0.01s-1 (move relative) was applied followed by a dynamic
sinusoid of amplitude; 0.05%, frequency; 1Hz, and 20 cycles). Four
microfracture holes were created with a 20o awl (Arthrex, Naples FL)
at 70, 55 and 40 degrees to the joint surface. After non-destructive
testing was repeated all samples underwent compressive testing to
failure using preload of 30N and a rate of 0.01s-1 to a peak strain of
25%.
Results: Microfracture signiﬁcantly reduced the stiffness of sub-
chondral bone (p< .0.025 T-Test) but therewas no effect of awl angle on
subchondral bone stiffness after microfracture. (p < .77, paired T-test).
Failure was through barreling and outward displacement of trabeculae
than than through through the microfracture holes (2/42 samples).
Conclusions: Microfracture reduced the mechanical properties of the
supporting bone in this simpliﬁed protocol regardless of awl approach
angle. Bone compaction frommicrofracture is considered deleterious so
,plowing“ should be discouraged. Creating additional microfracture
holes spaced more closely together than currently recommended
should be done with caution because bone stiffness would be incre-
mentally affected.
